DIMETAPP CHILDREN'S COLD & FEVER 6.25 MG / 5 ML
PHENYLPROPANOLAMINE HYDROCHLORIDE : 6.25 MG / 5 ML ACETAMINOPHEN : 160 MG / 5 ML BROMPHENIRAMINE MALEATE : 1 MG / 5 ML · DIN 02241814 · WHITEHALL-ROBINS INC.
Health Canada status: CANCELLED POST MARKET
What is DIMETAPP CHILDREN'S COLD & FEVER?
DIMETAPP CHILDREN'S COLD & FEVER 6.25 MG / 5 ML contains PHENYLPROPANOLAMINE HYDROCHLORIDE : 6.25 MG / 5 ML ACETAMINOPHEN : 160 MG / 5 ML BROMPHENIRAMINE MALEATE : 1 MG / 5 ML. It is listed in the Health Canada Drug Product Database under DIN 02241814, held by WHITEHALL-ROBINS INC., supplied as LIQUID for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 10-Apr-2001. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02241814 |
|---|---|
| Brand name | DIMETAPP CHILDREN'S COLD & FEVER |
| Generic / active ingredient | PHENYLPROPANOLAMINE HYDROCHLORIDE : 6.25 MG / 5 ML ACETAMINOPHEN : 160 MG / 5 ML BROMPHENIRAMINE MALEATE : 1 MG / 5 ML |
| Manufacturer | WHITEHALL-ROBINS INC. |
| Strength | 6.25 MG / 5 ML |
| Dosage form | LIQUID |
| Route of administration | ORAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | N02BE51 ACETAMINOPHEN, COMB EXCL PSYCHOLEPTICS |
| AHFS class | 28:08.92 ; 04:04.20 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 10-Apr-2001 |
| Original market date | 2000-07-21 00:00:00 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 02241814 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2241814 |
| Brand name | DIMETAPP CHILDREN'S COLD & FEVER |
| Active ingredient / INN | PHENYLPROPANOLAMINE HYDROCHLORIDE : 6.25 MG / 5 ML ACETAMINOPHEN : 160 MG / 5 ML BROMPHENIRAMINE MALEATE : 1 MG / 5 ML |
| ATC code | N02BE51 |
| ATC anatomical main group | N — Nervous system |
| ATC therapeutic subgroup | N02 |
| AHFS class | 28:08.92 ; 04:04.20 |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| Biosimilar biologic | No |
| Market authorization holder | WHITEHALL-ROBINS INC. |
Which pack is which?
| Strength on the label | 6.25 MG / 5 ML |
|---|---|
| Dosage form | LIQUID |
| Route | ORAL |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation, because this listing covers more than one of them.
What can be used instead?
Other Canadian products sharing ATC code N02BE51 ACETAMINOPHEN, COMB EXCL PSYCHOLEPTICS. 133 of 747 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ACETAMINOPHEN WITH ANTIHISTAMINE NIGHTTIME | 25 MG | TABLET | LABORATOIRES TRIANON INC. | MARKETED | DIN 02238183 |
| ADVIL PLUS ACETAMINOPHEN | 125 MG | TABLET | HALEON CANADA ULC | MARKETED | DIN 02519267 |
| BENADRYL ALLERGY, SINUS & PAIN TOTAL | 25 MG | TABLET | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | MARKETED | DIN 02250993 |
| BENYLIN EXTRA STRENGTH ALL-IN-ONE COLD, FLU & COUGH | 100 MG | TABLET | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | MARKETED | DIN 02218186 |
| BENYLIN EXTRA STRENGTH ALL-IN-ONE COLD, FLU & COUGH NIGHT | 30 MG | TABLET | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | MARKETED | DIN 02256576 |
| BENYLIN EXTRA STRENGTH ALL-IN-ONE COUGH, COLD & FLU | 500 MG / 15 ML | SYRUP | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | MARKETED | DIN 02245710 |
| BENYLIN EXTRA STRENGTH ALL-IN-ONE COUGH, COLD & FLU NIGHT | 2 MG / 15 ML | SYRUP | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | MARKETED | DIN 02252376 |
| BENYLIN EXTRA STRENGTH ALL-IN-ONE COUGH, COLD & FLU WITH WARMING SENSATION | 30 MG / 15 ML | SYRUP | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | MARKETED | DIN 02321432 |
| BENYLIN EXTRA STRENGTH COLD & SINUS DAY | 5 MG | TABLET | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | MARKETED | DIN 02273462 |
| BENYLIN EXTRA STRENGTH COLD & SINUS NIGHT | 2 MG | TABLET | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | MARKETED | DIN 02306409 |
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.